Editorial introductions
Molecular pathology of prostate cancer revealed by next-generation sequencing
The promise of heat shock protein inhibitors in the treatment of castration resistant prostate cancer
Castrate-resistant prostate cancer
Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer
Lessons from in-vivo models of castration-resistant prostate cancer
Novel chemotherapies in development for management of castration-resistant prostate cancer
Imaging of castration-resistant prostrate cancer
Active surveillance
Active surveillance
Predicting high-risk disease using tissue biomarkers
Predicting high risk disease using serum and DNA biomarkers
The role of MRI in active surveillance of prostate cancer
Active surveillance
Psychosocial aspects of active surveillance
The economics of active surveillance for prostate cancer
Current World Literature